Established in 2006 as the Life Sciences Corporate Finance arm of Cukierman & Co. Investment House, Cukierman & Co. Life Sciences (CLS) provides investment banking services to private and public companies, at different stages of development, across the whole healthcare spectrum, in Israel, Europe, America and Asia.
CLS mission is to assist biotechnology, pharmaceuticals, diagnostics, medical devices and digital health companies in identifying, negotiating and closing equity and debt financing, licensing agreements, strategic partnerships and M&A transactions; as well as to support venture capital & private equity funds, private investors & family offices, corporate funds & corporate development teams, in selecting, evaluating, acquiring and divesting assets, businesses and companies in all life sciences sectors.
CLS talented team of scientists, finance and business experts, together with our extensive international network, combines product and corporate guidance with global industry knowledge. Whether you are an investor, an entrepreneur or an executive in a large company, we will deliver the most professional investment banking services, including the right financial, scientific, clinical and marketing advice as well as generate creative ideas and sound solutions, in order to implement your strategies for success.